Search
for
Sort by
Research 301–330 of 1000+
- Steroid 5α-reductase inhibition by polymethoxyflavones
- PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery
- The naked truth: Sphynx and Devon Rex cat breed mutations in KRT71
- Ginseng phytochemicals as therapeutics in oncology: Recent perspectives
- Pathologic Diagnosis of Central Centrifugal Cicatricial Alopecia on Horizontal Sections
- Brown Adipose Tissue and Novel Management Strategies for Polycystic Ovary Syndrome Therapy
- Hair Casts: A Clinical and Electron Microscopic Study
- Novel inhibitors of 5α-reductase
- TRICHOSTASIS SPINULOSA
- Expression of NAD+dependent 15-hydroxyprostaglandin dehydrogenase and protection of prostaglandins in human hair follicle
- Evaluation of the Safety and Effectiveness of Nutritional Supplements for Treating Hair Loss
- Lamellar ichthyosis with pseudoexon activation in the transglutaminase 1 gene
- Novel splice site mutation in the <i>LIPH</i> gene in a patient with autosomal recessive woolly hair/hypotrichosis: Case report and published work review
- Clinical, biochemical and mutational findings in biotinidase deficiency among Malaysian population
- Molecular docking studies and ADME-Tox prediction of phytocompounds from Merremia peltata as a potential anti-alopecia treatment
- ICP5249 Promotes Hair Growth by Activating the AMPK-Autophagy Signaling Pathway
- Identification of a Novel Missense Mutation in the Fibroblast Growth Factor 5 Gene Associated with Longhair in the Maine Coon Cat
- Alopecia areata treated using CO2 fractional laser with different parameters
- Nevus Sebaceus With Novel HRAS Sequence Variant Mutation Misdiagnosed as Alopecia Areata
- Unexpectedly high carrier rates and genotype/phenotype correlation; LIPH mutations in Japanese autosomal recessive woolly hair/hypotrichosis
- Combined melanocytic nevus presenting with scalp alopecia associated with alopecia areata: Coincidence or causal?
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia